High Efficiency of Antiviral CD4+ Killer T CellsSteven Hildemann(Ipsen (France)), Dirk Homann(Miami Transplant Institute)PLoS ONEApril 2, 201310.1371/journal.pone.0060420Cited by 39SaveCiteExport RISWatch citationsRelated PapersImmunology of COVID-19: Current State of the Science|Immunity|2020|1.8k